The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Role of neurotrophic factors in depression
Abstract
Major depression is associated with reduced volumes in the hippocampus and prefrontal cortex, whereas antidepressant treatments promote several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation, in the hippocampus. Several neurotrophic factors are associated with depression or antidepressant action. Stress suppresses brain-derived neurotrophic factor (BDNF) synthesis in the hippocampus, at least partially through a sustained modification of chromatin structure. Essentially all antidepressant treatments increase BDNF synthesis and signaling in the hippocampus and prefrontal cortex. This signaling is required for the behavioral effects of antidepressant drugs in rodents, and increased BDNF levels in the hippocampus mimic the behavioral effects of antidepressants. However, injection of BDNF into the mesolimbic dopamine pathway produces an opposing depression-like response. One hypothesis emerging from these data proposes that mood disorders reflect failed function of critical neuronal networks, whereas a gradual network recovery through activity-dependent neuronal plasticity induces the antidepressant effect. Neurotrophic factors themselves do not control mood, but they act as necessary tools in the activity-dependent modulation of networks, the physiological function of which determines how a plastic change influences mood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These results lend substantial support to the neuroplasticity hypothesis of depression (sometimes referred to as the neurotrophin hypothesis) (11, 23–36).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [28]
In the citing paper
“A growing body of research suggests that neuroplasticity pathways play a significant role in the pathophysiology of depression and in the therapeutic mechanisms of antidepressant drugs (AD) [1,2,3].”
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787
Cited by
Sorted by citations
Items 301–400 of 667
Qiu, J., Hu, S.-Y., Zhang, C., Shi, G.-Q., Wang, S., & Xiang, T. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.01.004 · Cited by 44
Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review
Lazur, J., Hnatyk, K., Kała, K., Sułkowska‐Ziaja, K., & Muszyńska, B. (2023) · Antioxidants · doi:10.3390/antiox12030623 · Cited by 44
Vaghi, V., Polacchini, A., Baj, G., Pinheiro, V. L. M., Vicario, A., & Tongiorgi, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586719 · Cited by 42
Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression
Paslakis, G., Blum, W. F., & Deuschle, M. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.045 · Cited by 44
Tuon, T., Valvassori, S. S., Lopes-Borges, J., Fries, G. R., da Silva, L. A., Kapczinski, F. P., Quevedo, J., & Pinho, R. A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.030 · Cited by 42
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 44
Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
Tomasetti, C., Montemitro, C., Fiengo, A. L. C., Santone, C., Orsolini, L., Valchera, A., Carano, A., Pompili, M., Serafini, G., Perna, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190312102444 · Cited by 44
Neuroprotective Effect of Apigenin on Depressive-Like Behavior: Mechanistic Approach
Bijani, S., Dizaji, R., Sharafi, A., & Hosseini, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03473-0 · Cited by 42
Depressive-Like Parameters in Sepsis Survivor Rats
Comim, C. M., Cassol-Jr, O. J., Constantino, L. C., Petronilho, F. C., Constantino, L. D. S., Stertz, L., Kapczinski, F. P., Barichello, T., Quevedo, J., & Dal‐Pizzol, F. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9101-6 · Cited by 42
Antidepressant-Like Effects of Erythropoietin: A Focus on Behavioural and Hippocampal Processes
Osborn, M., Rustom, N., Clarke, M., Litteljohn, D., Rudyk, C., Anisman, H., & Hayley, S. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072813 · Cited by 41
New insights into the neurobiological mechanisms of major depressive disorders
Fakhoury, M. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.01.005 · Cited by 45
Hippocampal BDNF signaling restored with chronic asiaticoside treatment in depression-like mice
Luo, L., Liu, X., Mu, R.-H., Wu, Y.-J., Liu, B., Geng, D., Liu, Q., & Yi, L. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.03.006 · Cited by 43
A novel 5HT3 receptor–IGF1 mechanism distinct from SSRI-induced antidepressant effects
Kondo, M., Koyama, Y., Nakamura, Y., & Shimada, S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.87 · Cited by 41
Ghiglieri, V., Sgobio, C., Patassini, S., Bagetta, V., Fejtová, A., Giampà, C., Marinucci, S., Heyden, A., Gundelfinger, E. D., Fusco, F. R., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.23 · Cited by 41
Synaptic Abnormalities in the Infralimbic Cortex of a Model of Congenital Depression
Seese, R. R., Chen, L. Y., Cox, C. D., Schulz, D., Babayan, A. H., Bunney, W. E., Henn, F. A., Gall, C. M., & LYNCH, G. S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2434-13.2013 · Cited by 39
Lithium: a novel treatment for Alzheimer's disease?
Zhong, J., & Lee, W. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.4.375 · Cited by 41
Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women
Meyer, J. D., Koltyn, K. F., Stegner, A. J., Kim, J., & Cook, D. B. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.09.022 · Cited by 43
Allaman, I., Papp, M., Kraftsik, R., Fiumelli, H., Magistretti, P. J., & Martin, J. (2008) · PubMed · Cited by 40
Musazzi, L., Rimland, J. M., Ieraci, A., Racagni, G., Domenici, E., & Popoli, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001685 · Cited by 40
Zhu, K. Y., Xu, S. L., Choi, R. C. Y., Yan, A. L., Dong, T. T.-X., & Tsim, K. W. K. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/731385 · Cited by 39
Yang, J., Pei, Y., Pan, Y., Jia, J., Shi, C., Yu, Y., Deng, J., Li, B., Gong, X., Wang, X., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/107380 · Cited by 40
Conditional deletion of TrkB alters adult hippocampal neurogenesis and anxiety-related behavior
Bergami, M., Berninger, B., & Canossa, M. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.2.1.7349 · Cited by 43
Tebano, M. T., Martire, A., Chiodi, V., Ferrante, A., & Popoli, P. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.164 · Cited by 39
Glenn, M. J., Adams, R. S., & McClurg, L. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.018 · Cited by 36
Sannino, G., Pasqualini, L., Ricciardelli, E., Montilla, P., Soverchia, L., Ruggeri, B., Falcinelli, S., Renzi, A., Ludka, C., Kirchner, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7225 · Cited by 40
Novel Molecular Targets of Antidepressants
Jarończyk, M., & Walory, J. (2022) · Molecules · doi:10.3390/molecules27020533 · Cited by 40
Imipramine treatment reverses depressive‐like behavior in alloxan‐diabetic rats
Ceretta, L. B., Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Zappellini, G., de Aguiar, B. W., Pfaffenseller, B., Lersh, C., Kapczinski, F. P., & Quevedo, J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1285 · Cited by 36
Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., Dos-Anjos, S., Vargas, V. I., Romero, B., & Valdizán, E. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660736 · Cited by 37
Brain-Derived Neurotrophic Factor: The Neurotrophin Hypothesis of Psychopathology
Stein, D. J., Daniels, W. M. U., Savitz, J. B., & Harvey, B. H. (2008) · CNS Spectrums · doi:10.1017/s1092852900013997 · Cited by 38
miRNAs in depression vulnerability and resilience: novel targets for preventive strategies
Lopizzo, N., Zonca, V., Cattane, N., Pariante, C. M., & Cattaneo, A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02048-2 · Cited by 37
Nakagawasai, O., Yamada, K., Takahashi, K., Odaira, T., Sakuma, W., Ishizawa, D., Takahashi, N., Onuma, K., Hozumi, C., Nemoto, W., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112640 · Cited by 37
Chiba, S., Numakawa, T., Ninomiya, M., Yoon, H. S., & Kunugi, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1894-8 · Cited by 37
Fobian, K., Owczarek, S., Budtz, C., Bock, E., Berezin, V., & Pedersen, M. V. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22285 · Cited by 36
Vasconcelos, A. S., Oliveira, I. C. M., Vidal, L. M. T., Rodrigues, G. C., Gutierrez, S. J. C., Barbosa‐Filho, J. M., Vasconcelos, S. M. M., Fonteles, M. M. D. F., Gaspar, D. M., & de Sousa, F. C. F. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12120 · Cited by 36
Llorens-Martı́n, M., & Trejo, J. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028376 · Cited by 38
Torres-Sánchez, S., Pérez-Caballero, L., & Berrocoso, E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.005 · Cited by 39
The antidepressant-like effect of formononetin on chronic corticosterone-treated mice
Zhang, C., Zhu, L., Lu, S., Li, M., Bai, M., Li, Y., & Xu, E. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147844 · Cited by 38
Depressão, antidepressivos e sistema imune: um novo olhar sobre um velho problema
Vismari, L., Alves, G. J., & Palermo‐Neto, J. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000500004 · Cited by 37
Dai, Y., Ban, W., & Yang, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179540 · Cited by 35
Dipeptide tyrosyl-leucine exhibits antidepressant-like activity in mice
Mizushige, T., Uchida, T., & Ohinata, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59039-7 · Cited by 35
Mokoena, M. L., Harvey, B. H., Oliver, D. W., & Brink, C. B. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9189-7 · Cited by 35
Peony glycosides reverse the effects of corticosterone on behavior and brain BDNF expression in rats
Mao, Q., Huang, Z., Ip, S., Xian, Y., & Che, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.016 · Cited by 37
From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation
Krasner, H., Ong, C. V., Hewitt, P., & Vida, T. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073219 · Cited by 40
Emanuel Miller Lecture: Early onset depressions – meanings, mechanisms and processes
Goodyer, I. M. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01964.x · Cited by 35
Kim, H. K., Blumberger, D. M., Downar, J. H., & Daskalakis, Z. J. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.11.025 · Cited by 39
Mao, Q., Huang, Z., Zhong, X., Feng, C.-R., Pan, A.-J., Li, Z., Ip, S., & Che, C. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.01.050 · Cited by 36
Dagyte, G., Luiten, P. G., De Jager, T., Gabriel, C., Mocaër, E., Den Boer, J. A., & Van der Zee, E. A. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22697 · Cited by 32
Berghauzen-Maciejewska, K., Wardas, J., Kosmowska, B., Głowacka, U., Kuter, K. Z., & Ossowska, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117698 · Cited by 34
Dedoni, S., Olianas, M. C., Ingianni, A., & Onali, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07766.x · Cited by 35
From non-pharmacological treatments for post-traumatic stress disorder to novel therapeutic targets
Hendriksen, H., Olivier, B., & Oosting, R. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.031 · Cited by 35
Apoptosis time course in the limbic system after myocardial infarction in the rat
Kaloustian, S., Wann, B. P., Bah, T. M., Girard, S., Apostolakis, A., Ishak, S., Mathieu, S., Ryvlin, P., Godbout, R., & Rousseau, G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.019 · Cited by 32
The CB1 Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin
Hassanzadeh, P., & Hassanzadeh, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0716-2 · Cited by 33
Piermartiri, T., Pan, H., Figueiredo, T. H., & Marini, A. M. (2015) · Molecules · doi:10.3390/molecules201119698 · Cited by 33
Thomas, R. M., & Peterson, D. A. (2008) · Europe PMC (PubMed Central) · Cited by 34
Rapid antidepressant effects: moving right along
Martinowich, K., Jimenez, D. V., Zarate, C. A., & Manji, H. K. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.55 · Cited by 34
Jindal, A., Mahesh, R., & Bhatt, S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.02.017 · Cited by 33
Kulesskaya, N., Karpova, N. N., Ma, L., Tian, L., & Võikar, V. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00257 · Cited by 31
Randesi, M., Zhou, Y., Mazid, S., Odell, S. C., Gray, J. D., da Rosa, J. C., McEwen, B. S., Milner, T. A., & Kreek, M. J. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.01.001 · Cited by 32
Liu, J., Li, Z., Liu, Y.-S., Chu, H.-D., Hu, N.-Y., Wu, D., Huang, L., Li, S.-J., Li, X., Yang, J., et al. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00474-x · Cited by 31
Saponins: the phytochemical with an emerging potential for curing clinical depression
Abbas, G., Rauf, K., & Mahmood, W. (2014) · Natural Product Research · doi:10.1080/14786419.2014.942661 · Cited by 33
Tsoory, M., Guterman, A., & Richter‐Levin, G. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22203 · Cited by 30
Effect of social isolation stress on saliva BDNF in rat
Nakagawa, Y., To, M., Saruta, J., Yamamoto, Y., Yamamoto, T., Shimizu, T., Kamata, Y., Matsuo, M., & Tsukinoki, K. (2019) · Journal of Oral Science · doi:10.2334/josnusd.18-0409 · Cited by 31
Hochstrasser, T., Ehrlich, D., Sperner‐Unterweger, B., & Humpel, C. (2012) · Pharmacopsychiatry · doi:10.1055/s-0032-1314843 · Cited by 31
Jindal, A., Mahesh, R., & Bhatt, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3705-0 · Cited by 33
Spulber, S. D., Rantamäki, T., Nikkilä, O., Ċastrén, E., Weihe, P., Grandjean, P., & Ceccatelli, S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq216 · Cited by 31
The antidepressant effect of musk in an animal model of depression: a histopathological study
Ayuob, N. N., Ali, S. S., Suliaman, M. I., Wahab, M. G. A. E., & Ahmed, S. M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2468-9 · Cited by 29
Carnevali, L., Statello, R., Vacondio, F., Ferlenghi, F., Spadoni, G., Rivara, S., Mor, M., & Sgoifo, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.119 · Cited by 30
Creating Well-Being: Increased Creativity and proNGF Decrease following Quadrato Motor Training
Venditti, S., Verdone, L., Pesce, C., Tocci, N., Caserta, M., & Ben‐Soussan, T. D. (2015) · BioMed Research International · doi:10.1155/2015/275062 · Cited by 30
Nakagawasai, O., Nemoto, W., Onogi, H., Moriya, T., Lin, J.-R., Odaira, T., Yaoita, F., Ogawa, T., Ohta, K., Endo, Y., et al. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.033 · Cited by 30
Mood-state effects on amygdala volume in bipolar disorder
Foland‐Ross, L. C., Brooks, J. O., Mintz, J., Bartzokis, G., Townsend, J. D., Thompson, P. M., & Altshuler, L. L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.003 · Cited by 30
Potential Antidepressant Role of Neurotransmitter CART: Implications for Mental Disorders
Mao, P. (2011) · Depression Research and Treatment · doi:10.1155/2011/762139 · Cited by 29
Peng, Z., Xue, F., Zhou, C., Zhang, R., Wang, Y., Liu, L., Sang, H., Wang, H., & Tan, Q. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3193-8 · Cited by 31
The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections
László, A., Lénárt, L., Illésy, L., Fekete, A., & Nemcsik, J. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01973-6 · Cited by 33
Nakagawasai, O., Yamada, K., Odaira, T., Takahashi, K., Nemoto, W., Sakuma, W., Wakou, M., Lin, J.-R., & Tan–No, K. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.01.002 · Cited by 29
The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
Amidfar, M., Réus, G. Z., de Moura, A. B., Quevedo, J., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_14 · Cited by 31
Mannelli, L. D. C., Vivoli, E., Salvicchi, A., Schiavone, N., Koverech, A., Messano, M., Nicolai, R., Benatti, P., Bartolini, A., & Ghelardini, C. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2326-0 · Cited by 30
Takahashi, K., Kurokawa, K., Hong, L., Miyagawa, K., Mochida-Saito, A., Takeda, H., & Tsuji, M. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114671 · Cited by 28
Xiao, L., Kish, V. L., Benders, K. M., & Wu, Z.-X. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv117 · Cited by 28
Yan, T., Wu, B., Liao, Z., Liu, B., Zhao, X. D., Bi, K., & Jia, Y. (2016) · Phytotherapy Research · doi:10.1002/ptr.5651 · Cited by 29
Souza, L. C., Jessé, C. R., de Gomes, M. G., Fabbro, L. D., Goes, A. T. R., Donato, F., & Boeira, S. P. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2329-2 · Cited by 28
Furukawa‐Hibi, Y., Nitta, A., Ikeda, T., Morishita, K., Liu, W., Ibi, D., Alkam, T., Nabeshima, T., & Yamada, K. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.003 · Cited by 28
Lima, E. B. C., de Sousa, C. N. S., Vasconcelos, G. S., Meneses, L. N., Pereira, Y. F. E. S., Ximenes, N. C., Júnior, M. A. S., Matos, N. C. B., Brito, R., Miron, D., et al. (2016) · Journal of Natural Medicines · doi:10.1007/s11418-016-0970-8 · Cited by 27
Stanquini, L. A., Biojone, C., Guimarães, F. S., & Joca, S. R. L. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.28 · Cited by 27
Park, Y., & Lee, B.-H. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.03.31 · Cited by 28
Abdelbasset, W. K., Alrawaili, S. M., Nambi, G. S., Yassen, E., Moawd, S. A. A., & Ahmed, A. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05086-4 · Cited by 27
Sand, P. G., Langguth, B., Kleinjung, T., & Eichhammer, P. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)66014-2 · Cited by 28
Kim, T.-W., Lim, B., Kim, K.-J., Seo, J.-H., & Kim, C. (2015) · Journal of Exercise Rehabilitation · doi:10.12965/jer.150225 · Cited by 25
Miao, Z., Zhang, J., Li, Y., Li, X., Song, W., Sun, Z. S., & Wang, Y. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.032 · Cited by 25
Rajamanickam, J., Annamalai, B., Rahbek‐Clemmensen, T., Sundaramurthy, S., Gether, U., Jayanthi, L. D., & Ramamoorthy, S. (2015) · Biochemical Journal · doi:10.1042/bj20140826 · Cited by 27
Norman, T. R., Cranston, I., Irons, J. A., Gabriel, C., Dekeyne, A., Millan, M. J., & Mocaër, E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.010 · Cited by 26
Yang, Y., Zhao, M., Zhang, Y., Shen, X., & Yuan, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2581 · Cited by 27
Lénárt, L., Balogh, D. B., Lénárt, N., Bárczi, A., Hosszú, Á., Farkas, T., Hodrea, J., Szabo, A. J., Szigeti, K., Dénes, Á., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4888-z · Cited by 26
Calsavara, A. J. C., Soriani, F. M., Vieira, L. Q., Costa, P. A., Rachid, M. A., & Teixiera, A. L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9610-8 · Cited by 26
The roles of valerenic acid on BDNF expression in the SH-SY5Y cell
Gönülalan, E. M., Bayazeid, O., Yalçın, F. N., & Demirezer, L. Ö. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.05.005 · Cited by 25
A review of the pharmacological action and mechanism of natural plant polysaccharides in depression
Yang, Y., Li, C.-X., Zhang, R., Shen, Y. H., Xu, X., & Yu, Q. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1348019 · Cited by 30
Ferreira, F. R., de Oliveira, A. M., Dinarte, A. R., Pinheiro, D. G., Greene, L. J., Silva, W. A., Joca, S. R. L., & Guimarães, F. S. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00757.x · Cited by 27
Hassanzadeh, P., Arbabi, E., Atyabi, F., & Dinarvand, R. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4188-3 · Cited by 26
Chen, L., Dai, J., Wang, Z., Zhang, H., Huang, Y.-F., & Zhao, Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/506735 · Cited by 24
Sanikhani, N. S., Modarressi, M. H., Jafari, P., Vousooghi, N., Shafei, S., Akbariqomi, M., Heidari, R., Lavasani, P. S., Yazarlou, F., Motevaseli, E., et al. (2020) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-020-09642-x · Cited by 26
Bobo, W. V., & Shelton, R. C. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903130609 · Cited by 24
Metadata
- Authors
- CASTREN, E., VOIKAR, V, & RANTAMAKI, T.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 7
- Issue
- 1
- Pages
- 18-21
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W1993636230
- Cited by
- 667
- References
- 32
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 17 · 2023: 20 · 2022: 13 · 2021: 24 · 2020: 30 · 2019: 23 · 2018: 31 · 2017: 32 · 2016: 33 · 2015: 57 · 2014: 38 · 2013: 40 · 2012: 59
- FWCI
- 25.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- neurotrophic factors, major depressive disorder, brain-derived neurotrophic factor, antidepressant mechanism, hippocampus, prefrontal cortex, neuroplasticity, neurogenesis, synaptogenesis, chronic stress, chromatin structure, mesolimbic dopamine system, activity-dependent plasticity, mood disorders
- MeSH terms
- Animals, Antidepressive Agents, Depression, Humans, Nerve Growth Factors, Stress, Physiological, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review